
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 28, 2022, titled "Glenmark Pharmaceuticals receives ANDA approval for Metronidazole Vaginal Gel, 0.75%".
Filed with NSE ·

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 28, 2022, titled "Glenmark Pharmaceuticals receives ANDA approval for Metronidazole Vaginal Gel, 0.75%".
6ix hasn’t read this filing yet.
Glenmark Pharmaceuticals Limited on 6ix
Follow Glenmark Pharmaceuticals into a list and get an email when it puts out news.
Follow Glenmark Pharmaceuticals